Treatment of erectile dysfunction in patients with Peyronie's disease using sildenafil citrate

@article{Levine2002TreatmentOE,
  title={Treatment of erectile dysfunction in patients with Peyronie's disease using sildenafil citrate},
  author={Laurence A. Levine and Kalyan C. Latchamsetty},
  journal={International Journal of Impotence Research},
  year={2002},
  volume={14},
  pages={478-482}
}
Erectile dysfunction (ED) has frequently been associated with Peyronie's Disease (PD) and may further compromise coitus. This is a retrospective analysis of ED in patients with PD since the release of sildenafil citrate (SC) focusing specifically on our patients' responses to SC. One-hundred seventy six patients with PD were evaluated between April 1998 and May 2001. All patients received a complete medical and sexual history, physical exam, penile duplex ultrasound (PDU, with 30–90 mg of… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 16 CITATIONS

Current and emerging treatment options for Peyronie’s disease

VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Daily Dosing of PDE5 Inhibitors: Where Does it Fit in?

  • Current Urology Reports
  • 2013
VIEW 2 EXCERPTS
CITES BACKGROUND

Effects of sildenafil treatment on patients with Peyronie’s disease and erectile dysfunction

  • Irish Journal of Medical Science (1971 -)
  • 2013
VIEW 2 EXCERPTS
CITES METHODS & BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 10 REFERENCES

Position paper : the process of care model for evaluation and treatment of erectile dysfunction

R Sadovsky, T Miller, M Moskowitz, G Hackett
  • Int J Impot Res
  • 1999

The Process of Care Consensus Panel. Position paper: the process of care model for evaluation and treatment of erectile dysfunction

R Sadovsky, T Miller, M Moskowitz, G. Hackett
  • Int J Impot Res
  • 1999